Lumos Health Advisory has opened applications for the second cohort of its healthcare speed-scaling programme, inviting early-stage healthtech and medtech startups from around the world to apply before the June 25, 2026 deadline.

Positioned as one of Asia’s leading healthcare-focused accelerator platforms, Lumos Health aims to help startups navigate the complex journey from innovation to commercialization by providing access to clinical infrastructure, regulatory expertise, healthcare networks, and investment opportunities.

Founded by healthcare entrepreneur Anjali Ajaikumar Rossi and venture capital leader Prasad Vanga, Lumos Health was established to address a critical challenge faced by healthcare startups: the need for more than just funding to successfully scale. 

The programme is designed to provide founders with the strategic support, clinical access, and ecosystem partnerships necessary to accelerate product development and market adoption.

The initiative is powered by a strategic collaboration between Anjali Ajaikumar Rossi, Director of HCG, and Anthill Ventures, a global venture capital fund with extensive investor and business networks across India, the United States, and Singapore. Through this partnership, participating startups gain access to both healthcare expertise and commercialization pathways.

Anjali Ajaikumar Rossi, Founder of Lumos Health, emphasized the importance of access to clinicians, patients, regulatory frameworks, and market pathways in helping startups transition from pilot projects to widespread adoption. 

Shubhendra Singh Thakur, CEO and Founder of ErlySign, noted that access to mentorship, clinical validation opportunities, and collaboration with healthcare institutions played a crucial role in transforming the company’s early-stage innovation into a validated healthcare solution with real-world impact.